Results 211 to 220 of about 612,065 (387)
Advanced Therapeutics, EarlyView.This study characterizes a camelid antibody (B10) with potent neutralizing activity against SARS‐CoV‐2 Wildtype and Omicron variants. Through binding assays, epitope mapping, pseudovirus neutralization, and AI‐driven modeling, the antibody is shown to target conserved RBD regions in a closed Spike conformation.
Katja Hanack +13 more
wiley +1 more source
Effect of antiserum against recombinant EGr_09888 on the in vitro development of Echinococcus granulosus protoscoleces. [PDF]
Parasitol ResPan XY +9 more
europepmc +1 more source
Differential impact of anthropogenic noise during the acoustic development of begging calls in Blue Tits (Cyanistes caeruleus) [PDF]
Javier Sierro +2 more
openalex +1 more source
572. Efficient High Titer Production of Recombinant Lentiviral Vectors for Cancer Immunotherapy [PDF]
, 2012 openalex +1 more source
Advanced Therapeutics, EarlyView.This review explores how antibody engineering and display technologies are driving therapeutic advances against mosquito‐borne orthoflaviviruses such as Zika, dengue, and yellow fever viruses. It highlights diverse neutralizing targets on the envelope protein, including the conserved fusion loop, and discusses how Fc engineering, rational antigen ...
Ana Clara Barbosa Antonelli +5 more
wiley +1 more source
In vitro virucidal activity of chemical compounds against porcine transmissible gastroenteritis virus and porcine respiratory coronavirus. [PDF]
BMC Vet ResAntas M, Olech M.
europepmc +1 more source
Antibody Titers to Propionibacterium acnes Cell Wall Carbohydrate in Nodulocysitc Acne Patients
, 1985 Guy Webster +2 more
openalex +1 more source